ImmuneWorks

Tolerance Bio, Inc.

This biopharmaceutical company develops thymus-based therapies to treat immune-mediated diseases including cancer, autoimmunity and transplant rejection for patients requiring restored immune tolerance.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Aqualung

Aqualung Therapeutics develops immunotherapeutic monoclonal antibodies for patients suffering from inflammatory lung injuries and life-threatening fibrosis.

Aboleris Pharma

This biopharmaceutical company develops immunomodulatory antibodies to treat autoimmune diseases and organ transplantation rejection for patients requiring restored immune tolerance.

Promedior

This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.

Human Immunology Biosciences (HI-Bio)

This biotechnology company develops targeted immunotherapies for patients with rare, severe immune-mediated diseases, such as chronic kidney conditions and antibody-mediated transplant rejection.

IMMvention Therapeutics

This biotechnology firm develops small molecule oral therapies for patients with sickle cell disease and other inflammatory or neurodegenerative conditions.